Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10293 |
| Vaccine Name | GLS-5300 (INO-4700) |
| Disease Name | MERS |
| Disease Classification | Respiratory |
| Virus Name | MERS-CoV |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | DNA based vaccine |
| Vaccine Status | Phase 2 |
| Manufacturer | GeneOne Life Science Inc. |
| Year of Manufacturing | 2020 |
| Manufacturing Country | South Korea |
| Age | 19 - 70 years |
| Dosage | 3 doses |
| Administration Route | Intradermal |
| Adjuvant | NA |
| Target Strain | MERS CoV spike glycoprotein |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | Inovio Pharmaceuticals, International Vaccine Institute |
| Other Countries | NA |
| Trade Name | GLS-5300 |
| PMID | NA |
| Clinical Trial ID | NCT03721718 |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749790/ |
| Additional Links | NA |